Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma

Article

Abstract: Introduction: Pheochromocytomas and paragangliomas (Pheo/PGL) are rare, vascular, sometimes malignan

Palabras claves:

Metastatic, Paraganglioma, Pazopanib, Takotsubo cardiomyopathy

Autores:

Bible K.C., Burton J.K., Harris P., Jasim S., Jimenez C., Richard J. Auchus, Sideras K., Suman V.J., Worden F.P.

Fuentes:

scopus